Generally well-tolerated when taken orally. The most common side effects, day-time drowsiness, headache and dizziness, appear to occur at the same frequency as with placebo. Other reported side effects include transient depressive symptoms, mild tremor, mild anxiety, abdominal cramps, irritability, reduced alertness, confusion, nausea, vomiting, and hypotension. Safety in Adults: Evidence indicates that it is likely safe to use in oral and parenteral forms for up to two months when used appropriately. Some evidence indicates that it can be safely used orally for up to 9 months in some patients. It is also likely safe to use topically when used appropriately. Safety in Children: Melatonin appeared to be used safely in small numbers of children enrolled in short-term clinical trials. However, concerns regarding safety in children have arisen based on their developmental state. Compared to adults over 20 years of age, people under 20 produce high levels of melatonin. Melatonin levels are inversely related to gonadal development and it is thought that exogenous administration of melatonin may adversely affect gonadal development. Safety during Pregnancy: High doses of melatonin administered orally or parenterally may inhibit ovulation. Not advised for use in individuals who are pregnant or trying to become pregnant. Safety during Lactation: Not recommended as safety has not be established.
Oral, rat: LD50 ≥3200 mg/kg
Melatonin is a biogenic amine that is found in animals, plants and microbes. Aaron B. Lerner of Yale University is credited for naming the hormone and for defining its chemical structure in 1958. In mammals, melatonin is produced by the pineal gland. The pineal gland is small endocrine gland, about the size of a rice grain and shaped like a pine cone (hence the name), that is located in the center of the brain (rostro-dorsal to the superior colliculus) but outside the blood-brain barrier. The secretion of melatonin increases in darkness and decreases during exposure to light, thereby regulating the circadian rhythms of several biological functions, including the sleep-wake cycle. In particular, melatonin regulates the sleep-wake cycle by chemically causing drowsiness and lowering the body temperature. Melatonin is also implicated in the regulation of mood, learning and memory, immune activity, dreaming, fertility and reproduction. Melatonin is also an effective antioxidant. Most of the actions of melatonin are mediated through the binding and activation of melatonin receptors. Individuals with autism spectrum disorders (ASD) may have lower than normal levels of melatonin. A 2008 study found that unaffected parents of individuals with ASD also have lower melatonin levels, and that the deficits were associated with low activity of the ASMT gene, which encodes the last enzyme of melatonin synthesis. Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Deferasirox | The serum concentration of Melatonin can be increased when it is combined with Deferasirox. |
| Peginterferon alfa-2b | The serum concentration of Melatonin can be increased when it is combined with Peginterferon alfa-2b. |
| Leflunomide | The serum concentration of Melatonin can be decreased when it is combined with Leflunomide. |
| Teriflunomide | The serum concentration of Melatonin can be decreased when it is combined with Teriflunomide. |
| Buprenorphine | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Hydrocodone | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Magnesium sulfate | The therapeutic efficacy of Melatonin can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Melatonin may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Mirtazapine | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Orphenadrine | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Pramipexole | Melatonin may increase the sedative activities of Pramipexole. |
| Ropinirole | Melatonin may increase the sedative activities of Ropinirole. |
| Rotigotine | Melatonin may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Melatonin. |
| Suvorexant | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Melatonin. |
| Thalidomide | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Isradipine | The therapeutic efficacy of Isradipine can be decreased when used in combination with Melatonin. |
| Diltiazem | The therapeutic efficacy of Diltiazem can be decreased when used in combination with Melatonin. |
| Trimethadione | The therapeutic efficacy of Trimethadione can be decreased when used in combination with Melatonin. |
| Amlodipine | The therapeutic efficacy of Amlodipine can be decreased when used in combination with Melatonin. |
| Nimodipine | The therapeutic efficacy of Nimodipine can be decreased when used in combination with Melatonin. |
| Nisoldipine | The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Melatonin. |
| Lercanidipine | The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Melatonin. |
| Cinnarizine | The therapeutic efficacy of Cinnarizine can be decreased when used in combination with Melatonin. |
| Ethosuximide | The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Melatonin. |
| Nicardipine | The therapeutic efficacy of Nicardipine can be decreased when used in combination with Melatonin. |
| Verapamil | The therapeutic efficacy of Verapamil can be decreased when used in combination with Melatonin. |
| Zonisamide | The therapeutic efficacy of Zonisamide can be decreased when used in combination with Melatonin. |
| Felodipine | The therapeutic efficacy of Felodipine can be decreased when used in combination with Melatonin. |
| Nitrendipine | The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Melatonin. |
| Perhexiline | The therapeutic efficacy of Perhexiline can be decreased when used in combination with Melatonin. |
| Nifedipine | The therapeutic efficacy of Nifedipine can be decreased when used in combination with Melatonin. |
| Amiodarone | The therapeutic efficacy of Amiodarone can be decreased when used in combination with Melatonin. |
| Carvedilol | The therapeutic efficacy of Carvedilol can be decreased when used in combination with Melatonin. |
| Bepridil | The therapeutic efficacy of Bepridil can be decreased when used in combination with Melatonin. |
| Mibefradil | The therapeutic efficacy of Mibefradil can be decreased when used in combination with Melatonin. |
| Nimesulide | The therapeutic efficacy of Nimesulide can be decreased when used in combination with Melatonin. |
| Prenylamine | The therapeutic efficacy of Prenylamine can be decreased when used in combination with Melatonin. |
| Cyclandelate | The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Melatonin. |
| Flunarizine | The therapeutic efficacy of Flunarizine can be decreased when used in combination with Melatonin. |
| Fluspirilene | The therapeutic efficacy of Fluspirilene can be decreased when used in combination with Melatonin. |
| Clevidipine | The therapeutic efficacy of Clevidipine can be decreased when used in combination with Melatonin. |
| Methsuximide | The therapeutic efficacy of Methsuximide can be decreased when used in combination with Melatonin. |
| Seletracetam | The therapeutic efficacy of Seletracetam can be decreased when used in combination with Melatonin. |
| Nylidrin | The therapeutic efficacy of Nylidrin can be decreased when used in combination with Melatonin. |
| Ziconotide | The therapeutic efficacy of Ziconotide can be decreased when used in combination with Melatonin. |
| Dotarizine | The therapeutic efficacy of Dotarizine can be decreased when used in combination with Melatonin. |
| Xylometazoline | The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Melatonin. |
| Nilvadipine | The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Melatonin. |
| Tranilast | The therapeutic efficacy of Tranilast can be decreased when used in combination with Melatonin. |
| Fasudil | The therapeutic efficacy of Fasudil can be decreased when used in combination with Melatonin. |
| Agmatine | The therapeutic efficacy of Agmatine can be decreased when used in combination with Melatonin. |
| Fendiline | The therapeutic efficacy of Fendiline can be decreased when used in combination with Melatonin. |
| Eperisone | The therapeutic efficacy of Eperisone can be decreased when used in combination with Melatonin. |
| Trimebutine | The therapeutic efficacy of Trimebutine can be decreased when used in combination with Melatonin. |
| Pinaverium | The therapeutic efficacy of Pinaverium can be decreased when used in combination with Melatonin. |
| Barnidipine | The therapeutic efficacy of Barnidipine can be decreased when used in combination with Melatonin. |
| Aranidipine | The therapeutic efficacy of Aranidipine can be decreased when used in combination with Melatonin. |
| Azelnidipine | The therapeutic efficacy of Azelnidipine can be decreased when used in combination with Melatonin. |
| Benidipine | The therapeutic efficacy of Benidipine can be decreased when used in combination with Melatonin. |
| Cilnidipine | The therapeutic efficacy of Cilnidipine can be decreased when used in combination with Melatonin. |
| Darodipine | The therapeutic efficacy of Darodipine can be decreased when used in combination with Melatonin. |
| Efonidipine | The therapeutic efficacy of Efonidipine can be decreased when used in combination with Melatonin. |
| Lacidipine | The therapeutic efficacy of Lacidipine can be decreased when used in combination with Melatonin. |
| Manidipine | The therapeutic efficacy of Manidipine can be decreased when used in combination with Melatonin. |
| Niguldipine | The therapeutic efficacy of Niguldipine can be decreased when used in combination with Melatonin. |
| Niludipine | The therapeutic efficacy of Niludipine can be decreased when used in combination with Melatonin. |
| Carboxyamidotriazole | The therapeutic efficacy of Carboxyamidotriazole can be decreased when used in combination with Melatonin. |
| Naftopidil | The therapeutic efficacy of Naftopidil can be decreased when used in combination with Melatonin. |
| Tetrahydropalmatine | The therapeutic efficacy of Tetrahydropalmatine can be decreased when used in combination with Melatonin. |
| Vinpocetine | The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Melatonin. |
| Gallopamil | The therapeutic efficacy of Gallopamil can be decreased when used in combination with Melatonin. |
| Bencyclane | The therapeutic efficacy of Bencyclane can be decreased when used in combination with Melatonin. |
| Otilonium | The therapeutic efficacy of Otilonium can be decreased when used in combination with Melatonin. |
| Terodiline | The therapeutic efficacy of Terodiline can be decreased when used in combination with Melatonin. |
| Lidoflazine | The therapeutic efficacy of Lidoflazine can be decreased when used in combination with Melatonin. |
| Penfluridol | The therapeutic efficacy of Penfluridol can be decreased when used in combination with Melatonin. |
| Caroverine | The therapeutic efficacy of Caroverine can be decreased when used in combination with Melatonin. |
| Dexverapamil | The therapeutic efficacy of Dexverapamil can be decreased when used in combination with Melatonin. |
| Emopamil | The therapeutic efficacy of Emopamil can be decreased when used in combination with Melatonin. |
| Lomerizine | The therapeutic efficacy of Lomerizine can be decreased when used in combination with Melatonin. |
| Tetrandrine | The therapeutic efficacy of Tetrandrine can be decreased when used in combination with Melatonin. |
| Dexniguldipine | The therapeutic efficacy of Dexniguldipine can be decreased when used in combination with Melatonin. |
| WIN 55212-2 | The therapeutic efficacy of WIN 55212-2 can be decreased when used in combination with Melatonin. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Melatonin. |
| Sodium oxybate | Melatonin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Succinic acid | The excretion of Succinic acid can be decreased when combined with Melatonin. |
| Citrulline | The excretion of Citrulline can be decreased when combined with Melatonin. |
| Pravastatin | The excretion of Pravastatin can be decreased when combined with Melatonin. |